BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20938627)

  • 1. [Multimodality therapy concepts for soft tissue sarcomas].
    Wendtner CM; Delank S; Eich H
    Internist (Berl); 2010 Nov; 51(11):1388-96. PubMed ID: 20938627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary gastrointestinal stromal tumor of the liver treated with sequential therapy.
    Lin XK; Zhang Q; Yang WL; Shou CH; Liu XS; Sun JY; Yu JR
    World J Gastroenterol; 2015 Feb; 21(8):2573-6. PubMed ID: 25741171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic therapy of soft tissue sarcomas].
    Pink D; Bertz-Lepel J; Reichardt P
    Pathologe; 2011 Feb; 32(1):65-71. PubMed ID: 21053001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in therapy for gastrointestinal stromal tumors.
    Maki RG
    Curr Oncol Rep; 2007 May; 9(3):165-9. PubMed ID: 17430686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors].
    Heger U; Weitz J; Lordick F
    Chirurg; 2008 Jul; 79(7):630-7. PubMed ID: 18548219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic therapy and hyperthermia for locally advanced soft tissue sarcoma].
    Lindner LH; Angele M; Dürr HR; Rauch J; Bruns C
    Chirurg; 2014 May; 85(5):398-403. PubMed ID: 24740176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
    Nishida T; Doi T; Naito Y
    Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspects of surgical treatment for gastro-intestinal stromal tumors].
    Hohenberger P
    Radiologe; 2009 Dec; 49(12):1122-7. PubMed ID: 19937425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal stromal tumors: imatinib and beyond.
    Schnadig ID; Blanke CD
    Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.
    Sjölund K; Andersson A; Nilsson E; Nilsson O; Ahlman H; Nilsson B
    World J Surg; 2010 Sep; 34(9):2090-7. PubMed ID: 20512492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib?
    Pantaleo MA; Di Battista M; Catena F; Astorino M; Saponara M; Di Scioscio V; Santini D; Piazzi G; Castellucci P; Brandi G; Biasco G
    J Cancer Res Clin Oncol; 2008 May; 134(5):625-30. PubMed ID: 18202855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy of gastrointestinal stromal tumors.
    Koshenkov VP; Rodgers SE
    Curr Opin Oncol; 2012 Jul; 24(4):414-8. PubMed ID: 22572723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
    Nishida T; Omori T; Ueshima S
    Gan To Kagaku Ryoho; 2011 May; 38(5):733-7. PubMed ID: 21566432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative chemotherapy and regional hyperthermia for high-risk adult-type soft tissue sarcomas.
    Lindner LH; Blay JY; Eggermont AMM; Issels RD
    Eur J Cancer; 2021 Apr; 147():164-169. PubMed ID: 33684876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.
    Hsu CC; Wu CE; Chen JS; Tseng JH; Chiang KC; Liu YY; Tsai CY; Cheng CT; Chen TW; Jan YY; Yeh TS; Chen YY; Yeh CN
    Anticancer Res; 2014 Sep; 34(9):5029-36. PubMed ID: 25202087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rechallenge of drugs in the era of targeted therapy.
    Nishida T; Doi T
    Lancet Oncol; 2013 Nov; 14(12):1143-5. PubMed ID: 24140185
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
    Dematteo RP; Ballman KV; Antonescu CR; Maki RG; Pisters PW; Demetri GD; Blackstein ME; Blanke CD; von Mehren M; Brennan MF; Patel S; McCarter MD; Polikoff JA; Tan BR; Owzar K;
    Lancet; 2009 Mar; 373(9669):1097-104. PubMed ID: 19303137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curative resection for bulky rectal gastrointestinal stromal tumor after neoadjuvant imatinib mesylate].
    Kobayashi H; Uetake H; Higuchi T; Enomoto M; Yasuno M; Iida S; Yoshimura T; Ishikawa T; Ishiguro M; Kato S; Ono H; Kikuchi A; Yamauchi S; Sugihara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2620-2. PubMed ID: 21224658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodal management in soft tissue sarcoma of the trunk and extremities].
    Ghadimi MP; Rehders A; Knoefel WT
    Chirurg; 2014 May; 85(5):378-82. PubMed ID: 24733613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumors of the stomach.
    Bennett JJ; Rubino MS
    Surg Oncol Clin N Am; 2012 Jan; 21(1):21-33. PubMed ID: 22098829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.